Skip to main content
NCBI home page
Journal of Clinical Microbiology logoLink to Journal of Clinical Microbiology
. 1992 Jun;30(6):1605–1607. doi: 10.1128/jcm.30.6.1605-1607.1992

Sensitive and specific polymerase chain reaction assays for diagnosis of human T-cell lymphotropic virus type I (HTLV-I) and HTLV-II infections in HTLV-I/II-seropositive individuals.

W Heneine 1, R F Khabbaz 1, R B Lal 1, J E Kaplan 1
PMCID: PMC265343  PMID: 1624585

Abstract

To confirm and differentiate between human T-cell lymphotropic virus type I (HTLV-I) and HTLV-II infections, we analyzed by polymerase chain reaction (PCR) samples of peripheral blood lymphocytes from 98 individuals seropositive for HTLV-I/II using pol (SK110/111) and tax (SK43/44) consensus primer pairs. A total of 96 samples (97.9%) were positive by the tax generic probe, while 95 were typed by the HTLV-I and HTLV-II pol probes. The three pol-negative samples were successfully amplified and typed by nested PCR with primers internal to SK110 and SK111. Results of PCR with a lysate of leukocyte nuclei obtained by whole blood lysis were comparable to those obtained with peripheral blood lymphocytes from 16 HTLV-seropositive subjects.

Full text

PDF
1605

Images in this article

1606Image
on p.1606
1606Image
on p.1606

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Abbott M. A., Poiesz B. J., Byrne B. C., Kwok S., Sninsky J. J., Ehrlich G. D. Enzymatic gene amplification: qualitative and quantitative methods for detecting proviral DNA amplified in vitro. J Infect Dis. 1988 Dec;158(6):1158–1169. doi: 10.1093/infdis/158.6.1158. [DOI] [PubMed] [Google Scholar]
  2. Ehrlich G. D., Glaser J. B., LaVigne K., Quan D., Mildvan D., Sninsky J. J., Kwok S., Papsidero L., Poiesz B. J. Prevalence of human T-cell leukemia/lymphoma virus (HTLV) type II infection among high-risk individuals: type-specific identification of HTLVs by polymerase chain reaction. Blood. 1989 Oct;74(5):1658–1664. [PubMed] [Google Scholar]
  3. Heneine W., Kaplan J. E., Gracia F., Lal R., Roberts B., Levine P. H., Reeves W. C. HTLV-II endemicity among Guaymi Indians in Panama. N Engl J Med. 1991 Feb 21;324(8):565–565. doi: 10.1056/NEJM199102213240815. [DOI] [PubMed] [Google Scholar]
  4. Hjelle B. Human T-cell leukemia/lymphoma viruses. Life cycle, pathogenicity, epidemiology, and diagnosis. Arch Pathol Lab Med. 1991 May;115(5):440–450. [PubMed] [Google Scholar]
  5. Hjelle B., Scalf R., Swenson S. High frequency of human T-cell leukemia-lymphoma virus type II infection in New Mexico blood donors: determination by sequence-specific oligonucleotide hybridization. Blood. 1990 Aug 1;76(3):450–454. [PubMed] [Google Scholar]
  6. Khabbaz R. F., Heneine W., Grindon A., Hartley T. M., Shulman G., Kaplan J. Indeterminate HTLV serologic results in U.S. blood donors: are they due to HTLV-I or HTLV-II? J Acquir Immune Defic Syndr. 1992;5(4):400–404. [PubMed] [Google Scholar]
  7. Komurian F., Pelloquin F., de Thé G. In vivo genomic variability of human T-cell leukemia virus type I depends more upon geography than upon pathologies. J Virol. 1991 Jul;65(7):3770–3778. doi: 10.1128/jvi.65.7.3770-3778.1991. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Kwok S., Gallo D., Hanson C., McKinney N., Poiesz B., Sninsky J. J. High prevalence of HTLV-II among intravenous drug abusers: PCR confirmation and typing. AIDS Res Hum Retroviruses. 1990 Apr;6(4):561–565. doi: 10.1089/aid.1990.6.561. [DOI] [PubMed] [Google Scholar]
  9. Kwok S., Higuchi R. Avoiding false positives with PCR. Nature. 1989 May 18;339(6221):237–238. doi: 10.1038/339237a0. [DOI] [PubMed] [Google Scholar]
  10. Kwok S., Kellogg D., Ehrlich G., Poiesz B., Bhagavati S., Sninsky J. J. Characterization of a sequence of human T cell leukemia virus type I from a patient with chronic progressive myelopathy. J Infect Dis. 1988 Dec;158(6):1193–1197. doi: 10.1093/infdis/158.6.1193. [DOI] [PubMed] [Google Scholar]
  11. Kwok S., Lipka J. J., McKinney N., Kellogg D. E., Poiesz B., Foung S. K., Sninsky J. J. Low incidence of HTLV infections in random blood donors with indeterminate western blot patterns. Transfusion. 1990 Jul-Aug;30(6):491–494. doi: 10.1046/j.1537-2995.1990.30690333477.x. [DOI] [PubMed] [Google Scholar]
  12. Lal R. B., Heneine W., Rudolph D. L., Present W. B., Hofhienz D., Hartley T. M., Khabbaz R. F., Kaplan J. E. Synthetic peptide-based immunoassays for distinguishing between human T-cell lymphotropic virus type I and type II infections in seropositive individuals. J Clin Microbiol. 1991 Oct;29(10):2253–2258. doi: 10.1128/jcm.29.10.2253-2258.1991. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Lee H. H., Swanson P., Rosenblatt J. D., Chen I. S., Sherwood W. C., Smith D. E., Tegtmeier G. E., Fernando L. P., Fang C. T., Osame M. Relative prevalence and risk factors of HTLV-I and HTLV-II infection in US blood donors. Lancet. 1991 Jun 15;337(8755):1435–1439. doi: 10.1016/0140-6736(91)93126-t. [DOI] [PubMed] [Google Scholar]
  14. Lee H., Swanson P., Shorty V. S., Zack J. A., Rosenblatt J. D., Chen I. S. High rate of HTLV-II infection in seropositive i.v. drug abusers in New Orleans. Science. 1989 Apr 28;244(4903):471–475. doi: 10.1126/science.2655084. [DOI] [PubMed] [Google Scholar]
  15. Manns A., Blattner W. A. The epidemiology of the human T-cell lymphotrophic virus type I and type II: etiologic role in human disease. Transfusion. 1991 Jan;31(1):67–75. doi: 10.1046/j.1537-2995.1991.31191096189.x. [DOI] [PubMed] [Google Scholar]
  16. Rosenblatt J. D., Plaeger-Marshall S., Giorgi J. V., Swanson P., Chen I. S., Chin E., Wang H. J., Canavaggio M., Hausner M. A., Black A. C. A clinical, hematologic, and immunologic analysis of 21 HTLV-II-infected intravenous drug users. Blood. 1990 Jul 15;76(2):409–417. [PubMed] [Google Scholar]
  17. Villinger F., Powell J. D., Jehuda-Cohen T., Neckelmann N., Vuchetich M., De B., Folks T. M., McClure H. M., Ansari A. A. Detection of occult simian immunodeficiency virus SIVsmm infection in asymptomatic seronegative nonhuman primates and evidence for variation in SIV gag sequence between in vivo- and in vitro-propagated virus. J Virol. 1991 Apr;65(4):1855–1862. doi: 10.1128/jvi.65.4.1855-1862.1991. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Journal of Clinical Microbiology are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES